INDICATIONS AND ASSESSMENT FOR HEART TRANSPLANT
NT-pro B-Type Natriuretic Peptide (NT-pro BNP): Evidence is emerging to suggest that measurement of BNP as a prognostic marker may be a powerful tool. The St Paul’s Hospital Heart Transplant Program uses NT-proBNP (a form of BNP) in conjunction with the measurements outlined in CCS Guidelines to aid in transplant listing or delisting decisions. Currently, a level of 1,500pg/ml has been identified. Levels greater than this has been associated with significantly increased mortality in heart failure patients[2-5]
